Experimental design
The RNA-Seq benchmarking study described here utilized samples from a Phase 2, multi-center, double-blind randomized trial comparing the immunogenicity of two live attenuated vaccines against Experimental design of RNA-Seq benchmarking for the clinical vaccine study. 